April 15, 2021 11 a.m.End:
April 15, 2021 12:15 p.m.
Join the Entrepreneurship Center for the Entrepreneurial Lecture Series with Vineet Erasala, Manny Setegn, and Peeyush Shrivastava co-founders of Genetesis, Inc.
Genetesis is a medical technology company that provides biomagnetic imaging solutions.
Vineet Erasala is a proven product focused executive, specializing in full lifecycle medical device development and commercial access. A co-founder of Genetesis, Inc., He is highly proficient in technical and corporate strategy implementation efforts in fast-paced teams building breakthrough technology. At Genetesis, Vineet has effectively organized and managed teams in a variety of cross functional disciplines, including hardware engineering, executive management, manufacturing and field service operations, investor relations, and quality management in order to guide the company's biomagnetic technology through the R&D, manufacturing, and regulatory lifecycles. Vineet has a background in Electrical and Biomedical Engineering from Case Western Reserve University, with several years of experience in biomedical research, medical devices, and electronics engineering.
Manny Setegn is the co-founder and Chief Technology Officer of Genetesis, Inc. He studied Computer Science and Engineering + Economics at the Ohio State University, for 2 years before taking a leave of absence to pursue Genetesis as a full-time opportunity. He has approximately 9 years of programming experience, and 7 years in a professional setting. His background is in applied image processing, segmentation, reconstruction, and 3D imaging using a variety of complex algorithms to solve problems in medical computing. During the inception of Genetesis, he used his background to implement early forms of our system architecture to rapidly develop prototypes of 3D image viewers of hearts segmented from a 3D stack of MRI/CT images. Furthermore, he co-registered our proprietary datasets onto these anatomical images to provide further functional insights. More recently, he's adapted his skill set to be broadly applicable to include Web Development/Programming, System Architecture Design and Implementation, DevOps, Cloud technologies, and general end to end software delivery. He's been applying his cross-functional skill set to lead a team of skilled engineers with many disciplines to deliver the CardioFlux MCG to the mass market.
Peeyush Shrivastava has 8 years of experience as a serial medical device entrepreneur and technologist. He currently serves as co-founder and CEO of Genetesis, where he has raised over $20 million in venture capital financing and led the company through FDA approval and commercial launch of its flagship product, CardioFlux. Prior to Genetesis, Peeyush co-founded and served as the inaugural Chief Strategy Officer of Proscia, a leading digital health company where he managed business development efforts. Peeyush studied Biomedical Science at The Ohio State University, but left early to pursue his entrepreneurial efforts as a Thiel Fellow.
The lecture will be streamed live on the Entrepreneurship Center's Facebook page.